Christian Haddad

Christian Haddad’s ERC project ALTERBIOTIC investigates the global health crisis of antimicrobial resistance (AMR) by focusing on the political, economic, and innovation challenges involved in developing new, effective treatments for multi-drug-resistant ‘superbugs’. Drawing on science and technology studies, ALTERBIOTIC investigates current efforts to rebuild the antimicrobial innovation ecosystem by examining how key actors from science, industry, and policy imagine and pursue robust solutions to the AMR health and innovation crisis. The project maps emerging alternative clinical, regulatory, and economic approaches to drive biomedical R&D in this field and analyzes the complex “innovation challenges” related to the timely, sustainable, and equitable development of new, effective antibacterial therapies.